InVita Expands HemaConnect to Support Cell and Gene Therapy Donor Programs

Apr 23, 2026
InVita Healthcare Technologies and Gulf Coast Blood have introduced new capabilities in HemaConnect 2.5 to streamline donor recruitment and scheduling for cell and gene therapy programs.

InVita Healthcare Technologies and Gulf Coast Blood have introduced new advanced therapy capabilities in the latest HemaConnect 2.5 release, announced in a press release. The update enables blood centers to efficiently recruit, schedule, and track donors for specialized cell and gene therapy treatments.

Developed in collaboration between the two organizations, the new version includes configured profiles and workflows for therapy specific requirements, enhanced scheduling tools that connect interviews, sampling, and collections, and administrative features that coordinate traditional blood and advanced biotherapy collections.

The release aims to help blood centers use their existing donor networks to support regenerative medicine and other advanced treatments. HemaConnect currently supports most U.S. blood centers, managing millions of donor interactions each year through email, text, and call communications.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.